Literature DB >> 1624292

Botulinum a toxin for spasmodic torticollis: multiple vs single injection points per muscle.

G E Borodic1, L B Pearce, K Smith, M Joseph.   

Abstract

Eighty-six injections in 49 patients with adult onset spasmodic torticollis were evaluated for efficacy with respect to single point per muscle versus multiple point per muscle injection techniques. Parameters of the syndrome assessed were pain, posture deformity, range of cervical motion, disfigurement, cervical muscle hypertrophy, activity limitation, and degree of involuntary movement. The multiple point per muscle injection strategy appeared superior to the single injection per muscle technique with respect to pain (p less than 0.002, chi-square), posture deformity (p less than 0.001), range of motion (p less than 0.001), and improvement in activity endurance (p less than 0.001). No significant differences were noted with respect to cervical muscle hypertrophy or degree of involuntary movements, although the injections were considered beneficial in both groups to these syndrome components.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1624292     DOI: 10.1002/hed.2880140108

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  13 in total

1.  Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia.

Authors:  D Ranoux; C Gury; J Fondarai; J L Mas; M Zuber
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

Review 2.  Botulinum toxin for cerebral palsy; where are we now?

Authors:  R E Morton; J Hankinson; J Nicholson
Journal:  Arch Dis Child       Date:  2004-12       Impact factor: 3.791

Review 3.  Clinical Practice: Evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin.

Authors:  Maria Fiorella Contarino; Joost Van Den Dool; Yacov Balash; Kailash Bhatia; Nir Giladi; Johannes H Koelman; Annemette Lokkegaard; Maria J Marti; Miranda Postma; Maja Relja; Matej Skorvanek; Johannes D Speelman; Evelien Zoons; Joaquim J Ferreira; Marie Vidailhet; Alberto Albanese; Marina A J Tijssen
Journal:  Front Neurol       Date:  2017-02-24       Impact factor: 4.003

Review 4.  New concepts in botulinum toxin therapy.

Authors:  G E Borodic; L B Pearce
Journal:  Drug Saf       Date:  1994-09       Impact factor: 5.606

Review 5.  Guidelines for the therapeutic use of botulinum toxin in movement disorders. Italian Study Group for Movement Disorders, Italian Society of Neurology.

Authors:  A Berardelli; G Abbruzzese; L Bertolasi; G Cantarella; F Carella; A Currà; D De Grandis; G DeFazio; G Galardi; P Girlanda; P Livrea; N Modugno; A Priori; G Ruoppolo; L Vacca; M Manfredi
Journal:  Ital J Neurol Sci       Date:  1997-10

Review 6.  Focal dystonia: the role of botulinum toxin.

Authors:  R Tintner; J Jankovic
Journal:  Curr Neurol Neurosci Rep       Date:  2001-07       Impact factor: 5.081

7.  Botulinum toxin in the management of dystonia.

Authors:  Omar D Cardona-Garcia; Donald S Higgins; Eric S Molho
Journal:  Curr Treat Options Neurol       Date:  2007-05       Impact factor: 3.598

Review 8.  Management of cervical dystonia with botulinum neurotoxins and EMG/ultrasound guidance.

Authors:  Anna Castagna; Alberto Albanese
Journal:  Neurol Clin Pract       Date:  2019-02

9.  Unmet Needs in the Management of Cervical Dystonia.

Authors:  Maria Fiorella Contarino; Marenka Smit; Joost van den Dool; Jens Volkmann; Marina A J Tijssen
Journal:  Front Neurol       Date:  2016-09-28       Impact factor: 4.003

10.  Effect of the refrigerator storage time on the potency of botox for human extensor digitorum brevis muscle paralysis.

Authors:  Mee Young Park; Ki Young Ahn
Journal:  J Clin Neurol       Date:  2013-07-01       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.